Literature DB >> 26957881

Pharmaceutical Approval Update.

Chris Fellner.   

Abstract

Elbasvir/grazoprevir (Zepatier) for chronic hepatitis C virus; sumatriptin nasal powder (Onzetra Xsail) for migraine; eribulin mesylate (Halaven), now for liposarcoma; and extended-release amphetamine (Adzenys XR-ODT) for ADHD.

Entities:  

Year:  2016        PMID: 26957881      PMCID: PMC4771083     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  1 in total

1.  Elbasvir/Grazoprevir, an Alternative in Antiviral Hepatitis C Therapy in Patients under Amiodarone Treatment.

Authors:  Lina Weiss; Kerstin Wustmann; Mariam Semmo; Markus Schwerzmann; Nasser Semmo
Journal:  Case Rep Gastroenterol       Date:  2018-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.